Plasminogen activator inhibitor 1 (PAI-1), pentraxin-3 (PTX3) and myeloperoxidase (MPO) were also higher in MIS-C patients. This evidence concerns the gene MPO and COVID-19–associated multisystem inflammatory syndrome in children.